O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-6.13%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.66B
AUM Growth
+$4.66B
(-15%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
33.28%
Holding
137
New
14
Increased
16
Reduced
26
Closed
12
Top Buys
| 1 |
Merck
MRK
|
$109M |
| 2 |
Apollomics
APLM
|
$64.9M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$58.2M |
| 4 |
AbbVie
ABBV
|
$49.2M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$45.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$95.2M |
| 2 |
UnitedHealth
UNH
|
$87.7M |
| 3 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$87.7M |
| 4 |
Edwards Lifesciences
EW
|
$48.6M |
| 5 |
Baxter International
BAX
|
$42.8M |
Sector Composition
| 1 | Healthcare | 97.78% |
| 2 | Industrials | 1.11% |
| 3 | Consumer Staples | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
1
DELISTED
Sinovac Biotech, Ltd
SVA
| $340M | 7.22% | 2,718,735 | – | – |
|
2
Boston Scientific
BSX
$156B
| $175M | 3.71% | 3,306,800 -73,100 | -2% | -$3.86M |
|
3
Humana
HUM
$36.5B
| $167M | 3.54% | 342,500 -6,200 | -2% | -$3.02M |
|
4
Intuitive Surgical
ISRG
$170B
| $146M | 3.1% | 499,000 -121,500 | -20% | -$35.5M |
|
5
Biogen
BIIB
$19.4B
| $143M | 3.04% | 556,800 | – | – |
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $143M | 3.04% | 1,615,210 | – | – |
|
7
Enliven Therapeutics
ELVN
$1.2B
| $123M | 2.61% | 8,998,338 | – | – |
|
|
8
Merck
MRK
$210B
| $109M | 2.31% | +1,055,000 | New | +$109M |
|
9
Disc Medicine
IRON
$2.07B
| $107M | 2.27% | 2,269,637 | – | – |
|
10
Eli Lilly
LLY
$657B
| $99.9M | 2.12% | 186,000 | – | – |
|
11
Ionis Pharmaceuticals
IONS
$6.79B
| $98.4M | 2.09% | 2,169,500 | – | – |
|
|
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
| $91.8M | 1.95% | 3,968,588 -210,000 | -5% | -$4.86M |
|
13
United Therapeutics
UTHR
$13.8B
| $90.8M | 1.93% | 401,900 | – | – |
|
14
Crinetics Pharmaceuticals
CRNX
$2.92B
| $86.1M | 1.83% | 2,896,074 -1,054,722 | -27% | -$31.4M |
|
|
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $85.3M | 1.81% | 1,959,050 +1,045,400 | +114% | +$45.5M |
|
|
16
Baxter International
BAX
$12.7B
| $84.5M | 1.8% | 2,239,900 -1,135,100 | -34% | -$42.8M |
|
17
Edgewise Therapeutics
EWTX
$1.51B
| $83.5M | 1.77% | 14,567,176 | – | – |
|
18
Tenet Healthcare
THC
$16.3B
| $80.7M | 1.71% | 1,224,400 +263,900 | +27% | +$17.4M |
|
19
Xtant Medical Holdings
XTNT
$83.3M
| $80.4M | 1.71% | 73,114,592 | – | – |
|
20
Evolent Health
EVH
$1.12B
| $78.8M | 1.67% | 2,895,632 | – | – |
|
21
Stryker
SYK
$150B
| $73.5M | 1.56% | 269,000 -2,400 | -0.9% | -$656K |
|
22
Thermo Fisher Scientific
TMO
$186B
| $72.8M | 1.55% | 143,800 -19,000 | -12% | -$9.62M |
|
|
23
Apollomics
APLM
$4.34M
| $67.4M | 1.43% | 17,993,635 +17,331,074 | +2,616% | +$64.9M |
|
24
Cigna
CI
$80.3B
| $66.2M | 1.41% | 231,500 +70,500 | +44% | +$20.2M |
|
25
Sarepta Therapeutics
SRPT
$1.78B
| $64.1M | 1.36% | 529,200 -124,800 | -19% | -$15.1M |
|